BioNTech reports promising data on mRNA cocktail in mouse models of colon cancer and melanoma
A BioNTech-led team designed a cocktail of mRNAs that instruct cells to produce four cancer-fighting molecules.
iECURE emerges with $50M to search for ‘holy grail’ and ‘untapped frontier’ of gene editing
The biotech will use the funds for a slate of gene insertion programs for liver disorders out of the lab of gene therapy pioneer Jim Wilson, M.D., Ph.D. at Penn.
Philly life science firms raised more than $777M in the first half of 2021 alone
According to a new CBRE report, life science firms are on pace for a record year. Plus, a look at lab space occupancy.
One of Tachi’s newly born legacy biotechs raises $135M and enlists an A-list board to advance late-stage vaccine
Tachi Yamada's biotechs are continuing to make news.
Penn Medicine and Wharton Social Impact Initiative Launch New $5 Million Investment Initiative for Businesses that Improve Health of Philadelphians
Three start-up companies will be the first to receive investment from the Fund for Health, a joint partnership between Penn Medicine and the Wharton Social Impact Initiative.
Penn to play key role in the inaugural NSF Mid-Atlantic I-Corps Hub to advance entrepreneurship and technology commercialization training
PCI is proud to announce that Penn is one of the schools chosen to participate in the National Science Foundation’s new innovative I-Corps Hub initiative.
Wharton: Why declining entrepreneurship in the U.S. is not a concern
Technological improvements have changed the incentives of individuals to start their own business.
FDA awards Neuralert Technologies Breakthrough Device designation
The Center for Devices and Radiological Health (CDRH) of the FDA has granted the Neuralert Monitor designation as a Breakthrough Device.
Philadelphia-area VC funding smashes annual record just halfway through 2021
Philadelphia-area firms raised $3.1 billion in venture capital funding during the first half of 2021, already smashing an annual record set two years ago.